CHRISTOPHER ENGLERT: Open Payments
NPI 1578651485 · SPARKS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 89 payments from 16 companies in 2025. Trend: 2023 $1,304 · 2024 $1,824 · 2025 $1,970
Food & beverage: $1,892Education: $78
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $388 |
| Regeneron Healthcare Solutions, Inc. | 11 | $259 |
| Novartis Pharmaceuticals Corporation | 16 | $247 |
| Janssen Biotech, Inc. | 21 | $235 |
| PFIZER INC. | 8 | $219 |
| Arcutis Biotherapeutics, Inc. | 4 | $151 |
| Journey Medical Corporation | 2 | $122 |
| GENZYME CORPORATION | 3 | $109 |
| Botanix SB Inc | 2 | $51 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $38 |
Products named: Bimzelx, DUPIXENT, TREMFYA, COSENTYX, Zoryve, LITFULO, CIBINQO, SOFDRA.
Industry payments across MD — which companies pay providers there.
